Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Name: Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
License: Public Domain

Hipra Scientific, S.L.U

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19, sars-cov-2 acute respiratory disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 683130
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.